Revolution Medicines price target set at $255 by Morgan Stanley
Morgan Stanley initiated a $255.00 per-share price target for Revolution Medicines. Benzinga also reported the firm initiated the stock at Overweight.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.